+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Molecular Diagnostics Market by Product Type, Application, Technology, End User, Test Type - Global Forecast to 2030- Product Image
Molecular Diagnostics Market by Product Type, Application, Technology, End User, Test Type - Global Forecast to 2030- Product Image
Sale

Molecular Diagnostics Market by Product Type, Application, Technology, End User, Test Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5305518
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Molecular Diagnostics Market grew from USD 36.30 billion in 2024 to USD 42.40 billion in 2025. It is expected to continue growing at a CAGR of 16.01%, reaching USD 88.51 billion by 2030.

Setting the Stage for Molecular Diagnostics Innovation

Molecular diagnostics stands at the forefront of a healthcare revolution, transforming how diseases are detected, monitored, and treated. Over the past decade, advances in genomic sequencing, digital PCR, and bioinformatics have converged to deliver unprecedented levels of accuracy and speed. This evolution has empowered clinicians with actionable insights, driving personalized medicine from concept to clinical reality.

This executive summary distills the most critical developments shaping the molecular diagnostics landscape. Through rigorous analysis of market drivers, regulatory shifts, technological breakthroughs, and competitive dynamics, readers will gain a clear understanding of the forces propelling growth. By synthesizing key findings and outlining strategic imperatives, this overview equips decision-makers with the knowledge needed to navigate complexity and capitalize on emerging opportunities.

Navigating Transformative Forces Reshaping Molecular Diagnostics

The molecular diagnostics sector is undergoing transformative shifts that redefine traditional paradigms of testing and patient care. Rapid adoption of next-generation sequencing platforms has accelerated whole-genome and targeted panels, enabling earlier detection of rare genetic disorders and more precise oncology profiling. Concurrently, digital PCR technologies are delivering ultra-sensitive quantification of nucleic acids, broadening applications in liquid biopsy and infectious disease monitoring.

Moreover, integration of artificial intelligence and machine learning into data analysis workflows is revolutionizing interpretation, reducing turnaround times, and enhancing diagnostic accuracy. Regulatory frameworks are also adapting to these innovations, with harmonized guidelines emerging across major markets to facilitate faster approvals. Together, these forces are reshaping the molecular diagnostics landscape into a more agile, data-driven ecosystem, empowering stakeholders to deliver personalized, cost-effective solutions at scale.

Assessing the Cumulative Impact of US Tariffs on Diagnostics Supply Chains

In 2025, cumulative United States tariffs on imported reagents, instruments, and ancillary components have introduced new cost pressures across the molecular diagnostics supply chain. Higher duties on enzymes, reagents, and laboratory consumables have contributed to increased production expenses, prompting manufacturers to reevaluate sourcing strategies and optimize inventory management. These elevated costs are gradually being passed through to end users, affecting budget allocations within clinical laboratories and research institutions.

The tariff landscape has also triggered a strategic shift toward regional manufacturing and localized supply networks. By diversifying production sites and establishing partnerships with domestic suppliers, companies aim to mitigate the impact of additional duties. While this transition requires upfront investment and coordination, it offers long-term resilience against future trade policy fluctuations. As a result, stakeholders are poised to adopt hybrid sourcing models that balance cost efficiency with supply chain reliability.

Decoding Market Dynamics Through Granular Segmentation Analysis

A nuanced segmentation framework reveals the complexity and diversity underpinning the molecular diagnostics market. When examining product types, consumables and reagents dominate pricing dynamics, with enzymes and master mixes at the core of assay development, complemented by specialized kits and an expanding array of probes and primers. Instrumentation spans from compact benchtop devices to automated high-throughput platforms and emerging portable systems designed for point-of-need testing. In parallel, software and services deliver critical support, encompassing advanced data analysis tools that streamline genomic interpretation alongside maintenance programs that ensure operational excellence.

Considering applications, genetic testing drives significant investment, with carrier screening, diagnostic panels, and predictive assessments extending the reach of personalized medicine. Infectious disease testing remains essential, covering bacterial, parasitic, and viral targets to inform timely therapeutic interventions. Oncology applications are increasingly reliant on liquid biopsy techniques for minimal residual disease monitoring, while traditional tissue biopsy approaches continue to play a crucial role. Prenatal testing also demonstrates bifurcated growth, as both invasive diagnostic procedures and non-invasive maternal blood analyses expand clinical decision-making capabilities.

Technology classification further underscores market heterogeneity. Fluorescence in situ hybridization offers targeted detection of chromosomal abnormalities, while mass spectrometry and microarray analysis serve niche applications in biomarker discovery. Next-generation sequencing platforms, spanning exome, RNA, targeted gene panels, and whole genome workflows, have become indispensable for comprehensive profiling. Meanwhile, polymerase chain reaction technologies - including digital, multiplex, and real-time formats - maintain high utilization for routine pathogen detection and gene expression studies.

End-user segmentation highlights the critical roles of academic and research institutions driving discovery, diagnostic laboratories delivering high-complexity testing, hospitals and clinics integrating rapid diagnostics at the point of care, and reference laboratories providing centralized services. Test-type segmentation delineates between laboratory-based workflows within central, hospital, or independent labs and point-of-care modalities that encompass home testing kits and near-patient testing devices. This layered approach to segmentation illuminates the diverse channels through which molecular diagnostics innovations reach clinicians and patients globally.

Unveiling Regional Variations Driving Diagnostic Market Growth

Regional variations play a pivotal role in shaping the uptake and evolution of molecular diagnostics offerings. Within the Americas, robust R&D infrastructure, favorable reimbursement pathways, and large clinical trial pipelines drive sustained demand for advanced genomic and infectious disease assays. The presence of leading technology providers and well-established distribution networks further accelerates commercialization of cutting-edge solutions.

In Europe, the Middle East, and Africa, market dynamics are influenced by diverse regulatory frameworks and variable healthcare funding models. Western Europe continues to benefit from coordinated public health initiatives and harmonized regulatory pathways, while emerging markets in Eastern Europe and the Middle East invest heavily in modernizing laboratory infrastructure. Sub-Saharan African nations are gradually increasing adoption of molecular diagnostics to address endemic infectious diseases, supported by global health partnerships and donor programs.

The Asia-Pacific region represents the fastest-growing market segment, driven by growing healthcare expenditure in China, India, and Southeast Asia. Government initiatives aimed at strengthening domestic manufacturing capabilities, coupled with large patient populations and rising demand for early disease detection, are fueling expansion. Cross-border collaborations and technology transfer agreements are further accelerating regional capacity building, ensuring that innovative molecular diagnostics reach underserved communities.

Profiling Leading Innovators Steering the Molecular Diagnostics Arena

Key players across the molecular diagnostics landscape are continuously enhancing their portfolios through strategic partnerships, mergers, and targeted R&D investments. Leading instrument manufacturers are integrating digital analytics and automation to deliver platforms that cater to high-throughput sequencing, advanced PCR workflows, and point-of-care diagnostics. Concurrently, specialized reagent providers are innovating next-generation chemistries to improve sensitivity and streamline assay development.

Software developers are focusing on cloud-based solutions that enable real-time collaboration between laboratories and clinicians, while service providers are expanding maintenance networks and offering comprehensive training programs to optimize device uptime. Emerging challengers are carving out niches in liquid biopsy applications, novel biomarker discovery, and decentralized testing, often collaborating with academic institutions to accelerate validation and regulatory approval. Together, these dynamics underscore a competitive environment where innovation, quality, and customer support define market leadership.

Strategic Imperatives for Industry Leaders to Thrive in a Competitive Landscape

Industry leaders should prioritize the development of integrated diagnostic platforms that seamlessly combine instrumentation, reagents, and data analytics. By offering end-to-end solutions, companies can enhance user experience, reduce turnaround times, and secure long-term customer loyalty. In parallel, diversifying supply chains and establishing regional manufacturing hubs will mitigate risks associated with trade policy shifts and logistics disruptions, ensuring uninterrupted access to critical components.

Embracing artificial intelligence and machine learning within diagnostic workflows will unlock new levels of interpretative power, enabling earlier disease detection and more precise treatment stratification. Strategic collaborations with healthcare providers, academic centers, and technology firms can accelerate product validation and regulatory clearance. Finally, tailoring market entry strategies to regional nuances - from reimbursement mechanisms to clinician adoption patterns - will ensure that offerings resonate with local stakeholders and achieve sustainable growth.

Understanding the Rigorous Approach Behind Molecular Diagnostics Research

This market assessment is grounded in a multi-tiered research methodology, combining extensive secondary research with targeted primary interviews. Peer-reviewed journals, industry reports, regulatory filings, and corporate presentations provide the foundational data set, while direct consultations with key opinion leaders, laboratory directors, and procurement executives validate market trends and identify emerging use cases.

Quantitative data is triangulated using multiple sources to ensure accuracy and consistency. Segmentation modeling employs a bottom-up approach, integrating shipment volumes, pricing data, and adoption rates across technologies, applications, and regions. Qualitative insights are enriched through structured interviews and advisory panels, resulting in a comprehensive analysis that reflects the nuanced realities of the molecular diagnostics ecosystem.

Synthesis of Core Findings and Their Implications for Stakeholders

In synthesizing the core findings of this executive summary, it is evident that molecular diagnostics is at an inflection point, propelled by technological convergence, evolving regulatory landscapes, and shifting clinical paradigms. Stakeholders who align their strategic initiatives with granular market insights will be best positioned to capture emerging opportunities and deliver impactful solutions.

The interplay between regional market dynamics, supply chain resilience, and segmentation nuances outlines a roadmap for innovation and growth. As the industry continues to evolve, close collaboration between manufacturers, laboratories, and healthcare providers will be essential to translating scientific breakthroughs into tangible patient outcomes.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Consumables & Reagents
      • Enzymes & Master Mixes
      • Kits
      • Probes & Primers
    • Instruments
      • Benchtop
      • High-Throughput
      • Portable
    • Software & Services
      • Data Analysis Software
      • Support & Maintenance
  • Application
    • Genetic Testing
      • Carrier Testing
      • Diagnostic Testing
      • Predictive Testing
    • Infectious Disease
      • Bacterial
      • Parasitic
      • Viral
    • Oncology
      • Liquid Biopsy
      • Minimal Residual Disease
      • Tissue Biopsy
    • Prenatal Testing
      • Invasive
      • Non-Invasive
  • Technology
    • Fluorescence In Situ Hybridization
    • Mass Spectrometry
    • Microarray Analysis
    • Next-Generation Sequencing
      • Exome Sequencing
      • RNA Sequencing
      • Targeted Sequencing
      • Whole Genome Sequencing
    • Polymerase Chain Reaction
      • Digital PCR
      • Multiplex PCR
      • Real-Time PCR
  • End User
    • Academic & Research Institutes
    • Diagnostic Laboratories
    • Hospitals & Clinics
    • Reference Laboratories
  • Test Type
    • Laboratory Based
      • Central Lab
      • Hospital Lab
      • Independent Lab
    • Point Of Care
      • Home Testing
      • Near Patient Testing
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • QIAGEN N.V.
  • bioMérieux SA
  • Becton, Dickinson and Company
  • Hologic, Inc.
  • Siemens Healthineers AG
  • Sysmex Corporation

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Molecular Diagnostics Market, by Product Type
8.1. Introduction
8.2. Consumables & Reagents
8.2.1. Enzymes & Master Mixes
8.2.2. Kits
8.2.3. Probes & Primers
8.3. Instruments
8.3.1. Benchtop
8.3.2. High-Throughput
8.3.3. Portable
8.4. Software & Services
8.4.1. Data Analysis Software
8.4.2. Support & Maintenance
9. Molecular Diagnostics Market, by Application
9.1. Introduction
9.2. Genetic Testing
9.2.1. Carrier Testing
9.2.2. Diagnostic Testing
9.2.3. Predictive Testing
9.3. Infectious Disease
9.3.1. Bacterial
9.3.2. Parasitic
9.3.3. Viral
9.4. Oncology
9.4.1. Liquid Biopsy
9.4.2. Minimal Residual Disease
9.4.3. Tissue Biopsy
9.5. Prenatal Testing
9.5.1. Invasive
9.5.2. Non-Invasive
10. Molecular Diagnostics Market, by Technology
10.1. Introduction
10.2. Fluorescence in Situ Hybridization
10.3. Mass Spectrometry
10.4. Microarray Analysis
10.5. Next-Generation Sequencing
10.5.1. Exome Sequencing
10.5.2. RNA Sequencing
10.5.3. Targeted Sequencing
10.5.4. Whole Genome Sequencing
10.6. Polymerase Chain Reaction
10.6.1. Digital PCR
10.6.2. Multiplex PCR
10.6.3. Real-Time PCR
11. Molecular Diagnostics Market, by End User
11.1. Introduction
11.2. Academic & Research Institutes
11.3. Diagnostic Laboratories
11.4. Hospitals & Clinics
11.5. Reference Laboratories
12. Molecular Diagnostics Market, by Test Type
12.1. Introduction
12.2. Laboratory Based
12.2.1. Central Lab
12.2.2. Hospital Lab
12.2.3. Independent Lab
12.3. Point of Care
12.3.1. Home Testing
12.3.2. Near Patient Testing
13. Americas Molecular Diagnostics Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Molecular Diagnostics Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Molecular Diagnostics Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche Ltd.
16.3.2. Abbott Laboratories
16.3.3. Thermo Fisher Scientific Inc.
16.3.4. Danaher Corporation
16.3.5. QIAGEN N.V.
16.3.6. bioMérieux SA
16.3.7. Becton, Dickinson and Company
16.3.8. Hologic, Inc.
16.3.9. Siemens Healthineers AG
16.3.10. Sysmex Corporation
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. MOLECULAR DIAGNOSTICS MARKET MULTI-CURRENCY
FIGURE 2. MOLECULAR DIAGNOSTICS MARKET MULTI-LANGUAGE
FIGURE 3. MOLECULAR DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. MOLECULAR DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. MOLECULAR DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. MOLECULAR DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY ENZYMES & MASTER MIXES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY PROBES & PRIMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY BENCHTOP, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY HIGH-THROUGHPUT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY PORTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY SUPPORT & MAINTENANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY CARRIER TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY PREDICTIVE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY PARASITIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY VIRAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY MINIMAL RESIDUAL DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TISSUE BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY NON-INVASIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROARRAY ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY EXOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY MULTIPLEX PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY CENTRAL LAB, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY HOSPITAL LAB, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LAB, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY HOME TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEAR PATIENT TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 105. CANADA MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 106. CANADA MOLECULAR DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 107. CANADA MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 108. CANADA MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 109. CANADA MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. CANADA MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 111. CANADA MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 112. CANADA MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 113. CANADA MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 114. CANADA MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. CANADA MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 116. CANADA MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 117. CANADA MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. CANADA MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 119. CANADA MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 120. CANADA MOLECULAR DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 121. MEXICO MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. MEXICO MOLECULAR DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 123. MEXICO MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 124. MEXICO MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 125. MEXICO MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. MEXICO MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 127. MEXICO MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 128. MEXICO MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 129. MEXICO MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 130. MEXICO MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. MEXICO MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 132. MEXICO MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 133. MEXICO MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. MEXICO MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 135. MEXICO MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 136. MEXICO MOLECULAR DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL MOLECULAR DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL MOLECULAR DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. ARGENTINA MOLECULAR DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 155. ARGENTINA MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 156. ARGENTINA MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 157. ARGENTINA MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. ARGENTINA MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 159. ARGENTINA MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 160. ARGENTINA MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 161. ARGENTINA MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 162. ARGENTINA MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 163. ARGENTINA MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 164. ARGENTINA MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 167. ARGENTINA MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 168. ARGENTINA MOLECULAR DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM MOLECULAR DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 194. UNITED KINGDOM MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 196. UNITED KINGDOM MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 198. UNITED KINGDOM MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 200. UNITED KINGDOM MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM MOLECULAR DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 202. GERMANY MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 203. GERMANY MOLECULAR DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 204. GERMANY MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 205. GERMANY MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 206. GERMANY MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. GERMANY MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 208. GERMANY MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 209. GERMANY MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 210. GERMANY MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 211. GERMANY MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 212. GERMANY MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 213. GERMANY MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 214. GERMANY MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. GERMANY MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 216. GERMANY MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 217. GERMANY MOLECULAR DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 218. FRANCE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 219. FRANCE MOLECULAR DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 220. FRANCE MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 221. FRANCE MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 222. FRANCE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. FRANCE MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 224. FRANCE MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 225. FRANCE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 226. FRANCE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 227. FRANCE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 228. FRANCE MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 229. FRANCE MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 230. FRANCE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. FRANCE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 232. FRANCE MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 233. FRANCE MOLECULAR DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 235. RUSSIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 236. RUSSIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 237. RUSSIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 238. RUSSIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. RUSSIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 240. RUSSIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 241. RUSSIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 242. RUSSIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 243. RUSSIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 244. RUSSIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 245. RUSSIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 246. RUSSIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. RUSSIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 248. RUSSIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 249. RUSSIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 250. ITALY MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 251. ITALY MOLECULAR DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 252. ITALY MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 253. ITALY MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 254. ITALY MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. ITALY MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 256. ITALY MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 257. ITALY MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 258. ITALY MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 259. ITALY MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 260. ITALY MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 261. ITALY MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 262. ITALY MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. ITALY MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 264. ITALY MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 265. ITALY MOLECULAR DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 266. SPAIN MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 267. SPAIN MOLECULAR DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 268. SPAIN MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 269. SPAIN MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 270. SPAIN MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. SPAIN MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 272. SPAIN MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 273. SPAIN MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 274. SPAIN MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 275. SPAIN MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 276. SPAIN MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 277. SPAIN MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 278. SPAIN MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 279. SPAIN MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 280. SPAIN MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 281. SPAIN MOLECULAR DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES MOLECULAR DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 298. SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 300. SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 302. SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 304. SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 306. SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 308. SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 310. SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 312. SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2030 (USD MILLION)
TABLE 314. SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 316. SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 318. SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 320. SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 322. SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 324. SOUTH AFRICA MOLECULAR DIAGN

Companies Mentioned

The companies profiled in this Molecular Diagnostics market report include:
  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • QIAGEN N.V.
  • bioMérieux SA
  • Becton, Dickinson and Company
  • Hologic, Inc.
  • Siemens Healthineers AG
  • Sysmex Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages185
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 42.4 Billion
Forecasted Market Value ( USD ) by 2030 $ 88.51 Billion
Compound Annual Growth Rate16.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Molecular Diagnostics Market Industry Trends and Global Forecasts 2023-2035: Distribution by Product, Technology, Application, Sample Type, End Users and Key Geographical Regions - Product Image

Molecular Diagnostics Market Industry Trends and Global Forecasts 2023-2035: Distribution by Product, Technology, Application, Sample Type, End Users and Key Geographical Regions

  • Report
  • Global
From
United States Molecular Diagnostics Market Report Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Image

United States Molecular Diagnostics Market Report Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • 200 Pages
  • United States
From
North America Molecular Diagnostics Market By Country, Competition, Forecast and Opportunities, 2019-2029F - Product Image

North America Molecular Diagnostics Market By Country, Competition, Forecast and Opportunities, 2019-2029F

  • Report
  • 132 Pages
  • North America
From
Molecular Diagnostics - Product Image

Molecular Diagnostics

  • Newsletter
  • 100 Pages
  • Global
Point of Care Molecular Diagnostics Market by Product Type, Technology, Application, End User, Format - Global Forecast to 2030 - Product Image

Point of Care Molecular Diagnostics Market by Product Type, Technology, Application, End User, Format - Global Forecast to 2030

  • Report
  • 198 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.